 | Y-mAbs Therapeutics, Inc. | |||
| NMS : YMAB || Location: United States | ||||
$14.94-0.35 (-2.26%) |
0.28 M | 14.28 - 15.44 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 2.328 M |
| March 28, 2024 | 2.236 M |
| March 15, 2024 | 2.100 M |
| Feb. 29, 2024 | 2.174 M |
| Feb. 15, 2024 | 2.202 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.20 | -0.02 | 90.24% |
| 09/30/2023 | -0.19 | -0.18 | 5.56% |
| 06/30/2023 | -0.25 | -0.14 | 43.20% |
| 03/31/2023 | -0.32 | -0.15 | 53.83% |
| 12/31/2022 | -0.47 | 0.03 | 106.45% |
YMAB Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 43.777M | Shares Float | 25.357M |
| Short Float | 2.328M | Market Cap | 669.35M |
| Institution ownership | 66.27% | Insider ownership | 14.545% |
| Earnings Date | 05/10/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.49 | Forward EPS | -0.28 |